Effects of C12 Monoglycerides on Broilers
Our colleagues Jim Bryte and Arnaud Samson attended the Poultry Science Association Annual meeting in Louisville where they gave more details about a poster entitled "Effect of C12 monoglycerides at different concentrations on morbidity factors and performances in broilers".
Our colleagues Jim Bryte and Arnaud Samson attended the Poultry Science Association Annual meeting in Louisville where they gave more details about a poster entitled "Effect of C12 monoglycerides at different concentrations on morbidity factors and performances in broilers".
The study presented by Arnaud Samson focuses on the effects of α-monolaurin (C12 monoglycerides) on the health and performance of broilers. In response to concerns about antibiotic resistance, the research investigates the potential of α-monolaurin as an alternative to antibiotic growth promotors in poultry feed.
The trial was conducted over 35 days on broilers using five experimental treatments, including varying concentrations of α-monolaurin (0.30 to 0.72 kg/MT) and a competitor product. Key findings include:
- Morbidity: Broilers supplemented with α-monolaurin had significantly lower morbidity rates (5.3%) compared to the control group (9.0%).
- Pododermatitis: Broilers receiving α-monolaurin had improved pododermatitis scores, indicating better footpad & overall health.
- Growth Performance: There was no significant difference in growth metrics between the supplemented and control groups.
Overall, the study suggests that α-monolaurin can improve the health and welfare of broilers without negatively impacting their growth performance, making it a viable alternative to antibiotics for enhancing animal health.
Discover the poster below:
